Next Article in Journal
Volatile Composition, Antimicrobial Activity, and In Vitro Innate Immunomodulatory Activity of Echinacea purpurea (L.) Moench Essential Oils
Previous Article in Journal
Superior Valorisation of Juglans regia L. Leaves of Different Maturity through the Isolation of Bioactive Compounds
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Molecules
Volume 28
Issue 21
10.3390/molecules28217329
molecules-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles thumb_up
...
Endorse textsms
...
Comment
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Global Proteome-Wide Analysis of Cysteine S-Nitrosylation in Toxoplasma gondii

by
Zexiang Wang
*,
Jia Li
,
Qianqian Yang
and
Xiaolin Sun
College of Veterinary Medicine, Gansu Agricultural University, Lanzhou 730070, China
*
Author to whom correspondence should be addressed.
Molecules 2023, 28(21), 7329; https://doi.org/10.3390/molecules28217329
Submission received: 7 September 2023 / Revised: 17 October 2023 / Accepted: 23 October 2023 / Published: 29 October 2023
Browse Figures
Versions Notes

Abstract

:
Toxoplasma gondii transmits through various routes, rapidly proliferates during acute infection and causes toxoplasmosis, which is an important zoonotic disease in human and veterinary medicine. T. gondii can produce nitric oxide and derivatives, and S-nitrosylation contributes to their signaling transduction and post-translation regulation. To date, the S-nitrosylation proteome of T. gondii remains mystery. In this study, we reported the first S-nitrosylated proteome of T. gondii using mass spectrometry in combination with resin-assisted enrichment. We found that 637 proteins were S-nitrosylated, more than half of which were localized in the nucleus or cytoplasm. Motif analysis identified seven motifs. Of these motifs, five and two contained lysine and isoleucine, respectively. Gene Ontology enrichment revealed that S-nitrosylated proteins were primarily located in the inner membrane of mitochondria and other organelles. These S-nitrosylated proteins participated in diverse biological and metabolic processes, including organic acid binding, carboxylic acid binding ribose and phosphate biosynthesis. T. gondii S-nitrosylated proteins significantly contributed to glycolysis/gluconeogenesis and aminoacyl-tRNA biosynthesis. Moreover, 27 ribosomal proteins and 11 microneme proteins were identified as S-nitrosylated proteins, suggesting that proteins in the ribosome and microneme were predominantly S-nitrosylated. Protein–protein interaction analysis identified three subnetworks with high-relevancy ribosome, RNA transport and chaperonin complex components. These results imply that S-nitrosylated proteins of T. gondii are associated with protein translation in the ribosome, gene transcription, invasion and proliferation of T. gondii. Our research is the first to identify the S-nitrosylated proteomic profile of T. gondii and will provide direction to the ongoing investigation of the functions of S-nitrosylated proteins in T. gondii.

1. Introduction

Toxoplasmosis, caused by parasitic protozoa Toxoplasma gondii, is an important zoonotic disease in human and veterinary medicine and has been reported worldwide [1,2]. In some countries, over 60% of the population has either acquired T. gondii infection or was seropositive for T. gondii [1,3]. The T. gondii infection rate is influenced by several factors, such as environmental conditions and dietary habits [1]. People who eat undercooked or raw meat have high infection rates, and cats living in rural districts or stray cats are more susceptible to T. gondii infection and excretion oocysts than pet cats [2,3,4]. Sheep and pig meats are at a higher risk of contamination with tissue cysts than cattle meat. Oocysts excreted by cats are unnecessary for its contamination [1,5,6,7].
The genus Toxoplasma includes only one species, which is grouped into three dominant genotypes: Types I, II and III. The virulent Type I genotype can cause 100% mortality and the median lethal dose (LD50) for Type I is one parasite. Types II and III cause intermediate or no mortality in mice irrespective of the inoculating dose [8,9]. T. gondii can infect cells at the sporozoite, bradyzoite and tachyzoite stages [1,10]. Sporozoites are only present in the intestinal cells of definitive hosts, including members of the family Felidae, such as the domestic cat [11,12,13]. T. gondii are found in bradyzoite and tachyzoite forms in intermediate hosts who acquire the infection via various routes, such as intake of food and water contaminated with sporulated oocysts, ingestion of raw or underdone meat contaminated with viable tissue cysts, congenital transmission, transplantation of organs containing tachyzoites or cysts and blood transfusion [1,11]. The slowly replicating bradyzoites primarily cause chronic infections, whereas the rapidly replicating tachyzoites cause acute infections [1,14].
Similar to that in other protozoans, T. gondii produces nitric oxide (NO) and NO derivatives, indicating the presence of a natural or inducible NO synthase (NOS) in T. gondii [15,16]. S-nitrosylation was considered as the extensive mechanism of signaling transduction participated by NO and NO derivatives, in which the S-nitrosylation of cysteine was induced by stable and soluble peroxynitrite (H2O2 + NO2− → ONOO− + H2O) resulting from NO and ROS [17,18,19,20,21]. This modification was catalyzed by nitrosylase and denitrosylase to add and remove the nitrosyl group from the substrate, respectively [22,23]. In addition, S-nitrosylation indirectly mediated other modifications, such as disulfide bonds formation and phosphorylation [24,25,26]. Therefore, protein S-nitrosylation not only contributes to cell signaling, but also to protein post-translation regulation [21].
In protozoa, proteome-wide studies on protein S-nitrosylation are limited. Mule et al. used mass spectrometry combined with resin-assisted enrichment and identified and qualified S-nitrosylated proteins from Trypanosoma cruzi trypomastigotes and trypomastigotes incubated with the extracellular matrix (ECM). They provided the first S-nitrosylation proteome data in T. cruzi and indicated the modulatory function of protein S-nitrosylation on extracellular matrix incubation before T. cruzi infection of the mammalian host [21]. The S-nitrosylated proteome of T. gondii is still a mystery. In this study, the S-nitrosylation proteome profile of tachyzoites of the T. gondii RH strain was identified using mass spectrometry coupled with resin-assisted enrichment, and the function of S-nitrosylated proteins was analyzed using bioinformatics tools. Our results demonstrate the presence of S-nitrosylation in the proteome of T. gondii and lay the foundation for studies on the role of S-nitrosylated proteins in T. gondii.

2. Results

2.1. Global Detection of S-Nitrosylated Sites on T. gondii Proteins

The total protein obtained from T. gondii tachyzoites of the RH strain were digested and S-nitrosylated peptides were enriched using the iodoTMT reagent and anti-TMT antibody. The enriched peptides were identified using an easy n-LC 1200 high-performance liquid chromatography (HPLC) system. A total of 918 unique S-nitrosylated peptides, 983 nonredundant S-nitrosylated sites and 637 S-nitrosylated proteins were identified with FDR (false-discovery rate) (Figure 1A, Table S1 in Supplementary Materials). Among these 637 S-nitrosylated proteins, 427 (67.03%) and 128 (~20.09%) were S-nitrosylated at one cysteine residue and two cysteine residues, respectively (Figure 1B). Interestingly, 12.87% (82 out of 637) S-nitrosylated proteins were S-nitrosylated at multiple cysteine residues/sites (more than two S-nitrosylated sites). The prediction of S-nitrosylation sites and S-nitrosylated proteins in T. gondii using GPS SNO 1.0 software identified 5587 S-nitrosylated proteins (Table S2). The ratio between predicted vs. identified S-nitrosylated proteins was 8.77. A wide range of S-nitrosylated proteins (450 out of 637) characterized in this study were potential S-nitrosylated proteins as suggested by the GPS SNO 1.0 software, which accounted for 70.64% of total S-nitrosylated proteins characterized in this study.

2.2. Motifs of S-Nitrosylated Peptides

Motif-X was used to compare position-specific frequencies among 10 amino acids upstream and downstream of all S-nitrosylated cysteine (Cys) residues. Consensus sequence analysis was conducted across all 637 S-nitrosylated proteins identified. As shown in Figure 2A, we obtained seven putative consensus sequences, including CXXXXXXXXXK, KXXXXXXXXXC, CXXXXXK, CXXXXK, IXXXXXXXXXC, CK and CXI (where C indicates the Cys S-nitrosylated site, X represents any amino acid residue, K indicates lysine acid residue and I represents isoleucine acid residue), which matched 76, 72, 61, 58, 43, 41 and 38 S-nitrosylated protein sites identified in our study (Table 1). In addition, we used MoMo software (Version 5.5.4) and hierarchical cluster analysis to investigate the frequency of neighboring amino acid adjacent to S-nitrosylated Cys residues. The highest frequency of acid residues adjacent to S-nitrosylated Cys residues contained three hydrophilic amino acids (K positions ranging from −10 to −9, −7, +10, and +6 to +5; Y at position ranging from −2 to −1, and +8; E at −2) and two hydrophobic amino acids (I at −10 and +2; M at +7) (Figure 2B).

2.3. Functional Annotation of S-Nitrosylated Proteins

To elucidate the primary role of S-nitrosylated proteins in T. gondii, Gene Ontology (GO) functional classification was conducted and categorized using enriched GO terms at the second level in the three GO classes: biological process, cellular component and molecular function. In the biological process category, 132, 119 and 73 S-nitrosylated proteins were involved in the cellular process, metabolic process and biological regulation, respectively, accounting for 48.14% of all identified S-nitrosylated proteins in T. gondii (Figure 3). In the cellular component category, 152, 148 and 84 S-nitrosylated proteins were involved in the cell, intracellular and protein-containing complex, respectively (Figure 3). In the molecular function category, 101 and 110 S-nitrosylated proteins were associated with binding and catalytic activity, respectively (Figure 3). WoLF PSORT was used to analysis the subcellular localization of the identified S-nitrosylated proteins [27,28]. The S-nitrosylated proteins were mainly present in the nucleus (26.26%), cytoplasm (25.63%), plasma membrane (16.98%), mitochondria (13.36%) and extracellular region (12.42%) (Figure 4A). In COG/KOG analysis, most S-nitrosylated proteins were grouped into translation, ribosomal structure and biogenesis, post-translational modification, protein turnover, chaperones, intracellular trafficking, secretion and vesicular transport, and carbohydrate transport and metabolism (Figure 4B).

2.4. Functional Enrichment Analysis of S-Nitrosylated Proteins in T. gondii

To comprehensively understand the functions of S-nitrosylated proteins, GO enrichment and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway enrichment analyses were conducted in T. gondii. The results of the cellular component category in the GO enrichment analysis revealed that S-nitrosylated proteins were primarily located in the inner membrane of mitochondria and other organelle (Figure 5 and Figure S1). Organic acid binding and carboxylic acid binding were the two most significantly enriched categories under the molecular function. The ribose phosphate biosynthetic process was mostly enriched in biological process terms (Figure 5, Figures S2 and S3). Thereafter, the protein domain database was used to perform enriched protein domain analysis, which revealed that S-nitrosylated proteins were present in 25 domains. As shown in Figure 6A, S-nitrosylated proteins were significantly enriched in the PCI domain and elongation factor Tu domain 2 followed by anticodon binding and tRNA synthetase class II core (G, H, P, S and T) domains. The KEGG pathway analysis indicated that S-nitrosylated proteins mainly participated in glycolysis/gluconeogenesis and aminoacyl-tRNA biosynthesis. It is noteworthy that 19 and 17 S-nitrosylated proteins participated in glycolysis/gluconeogenesis and aminoacyl-tRNA biosynthesis pathways, respectively (Figure 6B).

2.5. Cysteine S-Nitrosylation of the Ribosome

Ribosomes are the site of protein synthesis, and ribosomal proteins are involved in protein translation and nuclease, transcription factor and cell signal regulation [29]. Studies have shown that >50% of the proteome of a protozoan comprises ribosomal proteins [29]. The ribosomes of T. gondii contain 79 ribosomal proteins [30,31]. Genes encoding ribosomal proteins are randomly located in the T. gondii genome, wherein 71 ribosomal proteins, there is a single locus across and eight loci paired at four locations in a head-to-head arrangement [30,31]. Of the 79 ribosomal proteins in T. gondii, 27 were S-nitrosylated and up to 35% of ribosomal proteins were S-nitrosylated (Table 2).

2.6. Cysteine S-Nitrosylation of Microneme Proteins in T. gondii

Micronemes, rhoptries and dense granules are three distinct regulated secretory organelles that which secrete various secretory proteins called micronemal proteins (MICs), rhoptry proteins (ROPs) and dense granule proteins (GRAs). It was suggested that MICs facilitate parasite attachment to host cells, ROPs enhance parasite vacuole formation and GRAs likely promote the replication of intracellular parasites [32]. In T. gondii, a number of secretory proteins (MICs, ROPs and GRAs) are considered as virulence-related p [30,33,34,35]. In our study, 22 secretory proteins, including 11 MICs, 10 ROPs and 1 GRA, were identified as S-nitrosylated proteins (Table 3). T. gondii micronemes contain approximately 20 types of MICs [36,37]. The findings of this study show that >50% of MICs are S-nitrosylated.

2.7. Protein–Protein Interaction Networks of S-Nitrosylated Proteins in T. gondii

To identify the critical biological processes influenced by S-nitrosylation in T. gondii, we conducted protein–protein interaction (PPI) analysis using the STRING database (Search Tool for the Retrieval of Interacting Genes/Protein, ver. 11.0, Wellcome Genome Campus, Hinxton, Cambridgeshire, UK, http://string-db.org/ accessed on 16 October 2023). We identified 204 S-nitrosylated proteins that were mapped to the 1607 protein–protein interactors. The S-nitrosylated PPI networks with high confidence (confidence score > 0.9) were identified by visualizing them using Cytoscape software (ver. 3.2.0, National Institute of General Medical Sciences, National Institutes of Health, Bethesda, MD, USA), which included 204 S-nitrosylated proteins mapped to 818 protein–protein interactors (Figure 7). Subsequently, several highly related subnetworks of S-nitrosylated proteins were identified using MCODE (Minimal Common Oncology Data Elements), including ribosome, RNA transport and chaperonin complex components (Figure 7), which were in agreement with the results obtained in COG/KOG analysis, suggesting that these processes play important roles in shaping the proteomic landscape of S-nitrosylation in T. gondii.

3. Discussion

NO is a critical and versatile molecule in the immune system that mediates redox regulation in eukaryotic cells when they are infected by unicellular parasites, including T. gondii [38]. Among protein PTMs, which regulate various mechanisms involved in cellular survival, growth and the biochemical network, S-nitrosylation is a versatile post-translational modification involved in several processes, such as RNS detoxification and cell cycle regulation [39]. S-nitrosylation affects protein function followed by an alteration in protein conformation, interaction between proteins, activity of enzymes or cellular location [40]. In this study, we identified the S-nitro proteome, a novel type of protein modification, in T. gondii.
It was infeasible to directly obtain pure and viable T. gondii tachyzoites from mouse peritoneal exudates or cell cultures, so it was crucial that we separated and purified tachyzoites in the process of conducting T. gondii research [41,42]. Human foreskin fibroblast (HFF) cells have long be used as the primary cell line to culture T. gondii in vitro [43]. It was reported that a confluent monolayer of HFF cells was lysed within 2 and 3 days post infection with ~5 × 106 tachyzoites and that over 90% of tachyzoites were released from HFF cells and were located outside the cell in the infected HFF monolayer [43]. So, extracellular tachyzoites were harvested after release from HFF cells 3~4 days post infection with ~5 × 106 tachyzoites in our study. Among four methods usually used for the purification of T. gondii tachyzoites cultured in vivo and in vitro, purification using a 3 μm filter membrane exhibited less contamination with host cells and high yield of tachyzoites [42,44]. This method for the purification of T. gondii tachyzoites had been widely used in PTMs proteomic profiling of T. gondii including identification of malonylated proteins and crotonylated proteins [27,45]. In the present study, harvested extracellular tachyzoites were also purified using a 3 μm filter membrane to eliminate cell debris. Highly purified tachyzoites without cell debris observed under a microscope were harvested for protein S-nitrosylation profiling.
Because of challenges concerned with the isolation, site-specific identification and quantification of labile and dynamic protein post-translational modifications, our overall understanding of cysteine-based reversible modifications, including S-nitrosylation, remains limited [46]. With regard to the profile of different reversible cysteine modifications together with S-nitrosylation, the sample pre-processing procedure was critical. Guo et al. optimized comprehensive conditions for selective reduction and possible negative or positive controls of specific types of reversible modifications, as well as the blocking of free thiols [46]. A number of previous reports have demonstrated that ascorbate is commonly applied to reduce S-nitrosylation [47,48]. This is consistent with our present study. Su et al. compared the specificity and coverage of enriched cysteine-containing peptides at both protein- and peptide-level enrichment, which showed that peptide-level enrichment has an advantage in the field of resin-binding capacity and is preferred when the amount of starting materials is large or the proteins are difficult to dissolve [47,48]. So, a peptide-level enrichment method was applied by most research studies and plentiful S-nitrosylated sites were identified [21,49,50,51]. In the isolation and purification of biochemical preparations or assays, DTT is widely used and forms a stable six-membered ring with an internal disulfide bond to disrupt S-S bonds formation and prevent protein aggregation [52,53]. In addition, DTT is also a commonly used reagent for total oxidation in the pre-processing procedure of total reversible cysteine modifications, and is able to prevent free thiols from oxidation during the profiling of S-nitrosylation [46,52]. Therefore, DTT is also used in the pretreatment process of the profiling of reversible cysteine modifications, including S-nitrosylation, as well as in our study [46,48].
Notably, T. gondii phosphofructokinase PFKII was the most nitrosylated protein (with nine nitrosylated sites), and was dispensable for tachyzoite growth or virulence [54]. PFKII-depleted parasites exhibited slower proliferation than PFKII-expressing parasites, whereas normal levels of ATP, a decrease in the flux of the glycolysis and tricarboxylic acid cycle, pyrophosphate accumulation and a reduction in protein synthesis in PFKII-depleted parasites proved by metabolic analyses suggested that PFKII plays a critical role in the maintenance of pyrophosphate homeostasis in T. gondii [54]. The second highly nitrosylated protein was anonymous antigen-1 (TGME49_312630), which was nitrosylated at eight sites. The function of this protein is unknown. Lactate dehydrogenase (LDH)1, harboring seven nitrosylated sites, was the third most nitrosylated protein. LDH1 is one of two LDH isoforms that catalyzes the interconversion of pyruvate and lactate to supply energy during anaerobic growth in T. gondii [55,56,57]. The growth rates of LDH1 or LDH2 knockdown parasites in either the tachyzoite or bradyzoite stages were different from those of the parental parasites, and differentiation processes in LDH1 or LDH2 knockdown parasites were downregulated when the parasites were grown under in vitro conditions. This indicates that LDH expression is important for the cell cycle of T. gondii [58]. The deletion of LDH1 in T. gondii not only displayed a reduction in acute parasite virulence and impairment of bradyzoite differentiation in vitro, but also decreased chronic-stage cyst burdens in vivo [55]. Thus, it can be inferred that Tg LDH1 is a critical regulator of virulence, bradyzoite differentiation and chronic infection in T. gondii [55].
Of the seven conserved motifs identified across the 637 S-nitrosylated cysteines using Motif-X, five motifs were basic amino acid lysine (K) and two were isoleucine (I). Studies on S-nitrosylation sites in proteins are limited; therefore, the consensus motif is unclear. Isabel Pérez-Mato et al. demonstrated that protein S-nitrosylation is governed by basic and acidic amino acids surrounding target cysteines of S-nitrosylated proteins [57]. Our finding suggests that the basic amino acid surrounding the target cysteines is possibly the major regulator of protein S-nitrosylation in T. gondii. The motif CXXXXXK characterized in this study possessed lysine at position +6 from the S-nitrosylated site. This lysine motif was also identified in the S-nitrosylated proteome of HeLa cell lysates and nuclear extracts from rat cortical neurons [59,60]. Theoretically, a linear distance between lysine and cysteine <6 Å intensified the nucleophilicity of the thiol group, making the cysteine more susceptible to nitrosylation, whereas the theoretical linear distance from lysine at position +6 from the S-nitrosylated site to cysteine was as far as ~20 Å [58,59]. It is reasonable to speculate that certain structural conformations of lysine present at +6 close to the target cysteine enhanced the vulnerability of cysteine to nitrosylation [58,59]. It is generally considered that S-nitrosylation is prone to be catalyzed by acidic amino acid and that it occurs in hydrophobic conditions, which stabilize S-nitrosylation through the sequestration of radical species and hydrolysis impedance of the process [53,60,61,62,63]. Combined characteristic acidic amino acid with basic lysine contained among the S-nitrosylation motifs reflected that protein nitrosylation was an indirect acid–base catalysis beyond direct acid–base catalysis [59]. Thus, the protein S-nitrosylation of T. gondii involves indirect acid–base catalysis or basic amino acid catalysis by motifs adjacent to the target cysteine.
Glycolysis/gluconeogenesis was the most significant pathway identified in the KEGG pathway enrichment analysis of protein S-nitrosylation in T. gondii. The S-nitrosylation of proteins involved in glycolysis seems to be a common process among protozoa. In Plasmodium falciparum, 11 glycolytic proteins were S-nitrosylated, reaching 3.4% (11 out of 319) of the total S-nitrosylated proteins [64]. In P. falciparum, the inhibition of S-nitrosylation at target site cysteine 153 of glyceraldehyde-3-phosphate dehydrogenase (GAPDH) remarkedly reduced the activity of PfGAPDH [64]. PfGAPDH may act as a signaling switch in P. falciparum for tolerance to nitrosative stress. Furthermore, the glycolysis pathway was indicated to be sensitive to redox modulation by NO [64]. A high-throughput proteomic analysis of S-nitrosylated proteins detected using resin-assisted capture in the gastrointestinal protozoan parasite Entamoeba histolytica revealed 14 proteins that participated in energy metabolism. Most of these proteins were S-nitrosylated proteins that were involved in glycolysis [65]. Interestingly, the GAPDH of Entamoeba histolytica was also an S-nitrosylated protein, which was similar to that of P. falciparum [64,65]. S-nitrosylation-modified proteins are also present in Trichomonas vaginalis. Protein nitrosylation was shown to regulate glycolysis in T. vaginalis and the number of glycolytic enzymes modified by SNO accounted for 17% of all S-nitrosylated proteins in T. vaginalis. The most representative LDH (TvLDH), one of the glycolytic enzymes, was also modified by S-nitrosylation. Adaption to the iron-deficient environment by T. vaginalis is dependent on the compensatory energy and nicotinamide adenine dinucleotide recycling provided by the S-nitrosylated TvLDH [65]. Accordingly, it is reasonable to assume that most S-nitrosylated proteins in T. gondii are enriched in glycolysis/gluconeogenesis.
PPI analysis performed by Minimal Common Oncology Data Elements identified three subnetworks with high relevancy: ribosome, RNA transport and chaperonin complex components. Studies have demonstrated that ribosomal proteins function as transcription factors, nucleases and regulators of cell signaling and also engage in protein translation [66,67]. Therefore, the percentage of ribosomal proteins in the SNO proteome is high [45,67,68,69]. The proportion of ribosomal proteins modified by SNO among the total number of S-nitrosylated protein was as high as 47% in T. vaginalis [65]. Our study characterized 27 S-nitrosylated ribosomal proteins, indicating that ribosomal proteins are susceptible to S-nitrosylation (Table 2). S-nitrosylated proteins in T. cruzi incubated with or without an extracellular matrix were present in large amounts in ribosomes. Notably, ribosomal proteins were one of the enriched protein complexes, as revealed by PPI network analysis in T. cruzi [21]. Consistently, our findings show that S-nitrosylated proteins in T. gondii were involved in protein translation in ribosomes. Studies have shown that S-nitrosylated proteins in some protozoa are mainly involved in transcription, such as histones [21,62,65]. It was not expected that RNA transport was the second highest relevant subnetwork in the PPI analysis of the S-nitrosylated proteome in T. gondii. Both S-nitrosylation and chaperone regulation majorly affected protein misfolding [63]. S-nitrosylation influenced target proteins involved in some key mechanisms, such as the folding, chaperone-mediated removal and refolding of misfolded proteins to prevent cell damage and accumulation of abnormal proteins [63]. S-nitrosylated chaperones in T. gondii formed the third subnetwork, i.e., the chaperonin complex component. The study of the effect of S-nitrosylated chaperones in T. gondii on its proliferation and virulence can yield interesting results. Among the 22 secretory proteins identified as S-nitrosylated protein in our study, 11 were located in the microneme, accounting for 50% of total MICs reported in the literature [36,37].
MICs play an important role in the initial stages of host cell invasion by T. gondii and many types of MICs are effective vaccine candidates against T. gondii [70,71]. In addition to nitrosylation, MICs are crotonylated at lysine residues [45]. Ten MICs (MIC1, MIC2, MIC3, MIC4, MIC6, MIC7, MIC8, MIC11, MIC13 and MIC15) are simultaneously crotonylated and nitrosylated. Moreover, several of these MICs are prominent virulent factors, such as MIC1, MIC3, MIC4, MIC6 and MIC8 [33,35]. MIC1, MIC4 and MIC6 assemble into a complex, which is critical for attachment and penetration into host cells during T. gondii infection [35]. MIC8 not only functions as an escort of soluble adhesions during invasion, but also participates in the intracellular replication of T. gondii [72]. Owing to its ability to generate humoral and cellular immune responses in MIC8-induced mice, it is considered a promising vaccine candidate against acute and chronic toxoplasmosis [45,71,73]. Thus, nitrosylation plays several roles during the invasion of T. gondii into the host cell. Further investigation of the function of MIC nitrosylation on the intracellular proliferation and virulence of T. gondii will be interesting and insightful.

4. Material and Methods

4.1. Ethics Approval

All animal experimental procedures were approved by the Animal Administration and Ethics Committee of Gansu Agricultural University (GSAU-Eth-VMC-2023-018), and performed in strict adherence to the Animal Ethics Procedures and Guidelines of the People’s Republic of China. Every effort was made to reduce the suffering of the animals used in the experiments.

4.2. Parasite Strains

Tachyzoites of T. gondii RH strain used in this study were provided by the State Key Laboratory of Veterinary Etiological Biology, Key Laboratory of Veterinary Parasitology of Gansu Province, Lanzhou Veterinary Research Institute, Chinese Academy of Agricultural Sciences. The RH strain used in our study was owned to type Ⅰ (ToxoDB#10) by applying PCR-restriction fragment length polymorphism (PCR-RFLP) [45,74].

4.3. Parasite Collection and Purification

Tachyzoites of T. gondii RH strain were maintained by serial passage in human foreskin fibroblast (HFF) monolayers. HFF monolayers were grown in Dulbecco’s modified Eagle’s medium (Gibco, Thermal Scientific, Waltham, MA, USA) containing 10% fetal calf serum (Gibco, Thermal Scientific, Waltham, MA, USA) and 100 U/mL penicillin–streptomycin in a 5% CO2 humidified incubator at 37 °C, as described [27,53]. A flask containing the HFF monolayer was infected with ~5 × 106 tachyzoites. The uninfected control HFF monolayer was also set up. A host–parasite ratio of 3:1 was used because it has been shown to yield a large number of parasites [75,76]. After infection was complete, HFF monolayer lysis and tachyzoites growth were examined every day. The infected HFF monolayer group contained free crescent-shaped tachyzoites in the cell culture medium, whereas no tachyzoites was observed in the uninfected HFF monolayer group. T. gondii infection of HFF monolayer was also characterized by subjecting the samples collected from the two groups to B1 gene amplification and PCR-RFLP. We found that samples from the uninfected HFF monolayer group did not contain tachyzoites, unlike the infected HFF monolayer group that contained tachyzoites of type I RH strain. In the infected HFF monolayer group, ~90% of tachyzoites were released from HFF cells and were located outside the cell 3~4 d after infection. Then, extracellular T. gondii tachyzoites and cell debris were harvested and washed several times with phosphate buffered saline [27,53] and passed through a 25-gauge needle. The parasites were filtered through a 3 μm filter membrane (Millipore) to remove HFF cell debris. This step was repeated three times until all cell debris was removed. The obtained sample was observed under a microscope to ensure that samples contained tachyzoites without cell debris. Purified parasites were centrifuged at 3000 rpm for 15 min and stored at −80 °C until use.

4.4. Protein Extraction

Tachyzoite pellets were sonicated for 3 min on ice using a high-intensity ultrasonic processor (Scientz) in lysis buffer (1%SDS, 1% protease inhibitor cocktail, 50 mM IAM, [pH 8.0]) and centrifuged at 12,000× g and 4 °C for 15 min in order to remove the remaining debris. Finally, protein concentration in the supernatant was measured using the Bradford assay.

4.5. Iodo-TMT Labeling

Briefly, 1 mg of each sample (2 μg/μL) was reduced with 10 mM arsenite at 37 °C for 1 h under dark conditions. After specific reduction, proteins were labeled with iodoTMT reagent 130 (ThermoFisher Scientific, Waltham, MA, USA), according to the manufacturer’s protocol, and incubated for 1 h at room temperature in dark.

4.6. Trypsin Digestion

Protein samples were mixed with one volume of precooled acetone vortexed and mixed with four volumes of prechilled acetone for precipitation at −20 °C for 2 h. The protein sample was re-dissolved in 200 mM tetraethyl ammonium bromide (TEAB) and ultrasonically dispersed. Protein samples were digested using trypsin at trypsin-to-protein mass ratio of 1:50 at 37 °C overnight. Then, the protein samples were reduced with dithiothreitol final concentration of 5 mM for 60 min at 37 °C and alkylated with iodoacetamide final concentration of 11 mM for 45 min at room temperature under darkness conditions. The samples were subjected to a second digestion using 1:100 trypsin-to-protein mass ratio for 4 h at 37 °C, desalted on a Strata X SPE column and vacuum-dried.

4.7. HPLC Fractionation

The sample was fractionated via high-pH reverse-phase HPLC performed using Agilent 300 Extend C18 column (5 μm particles, 4.6 mm ID and 250 mm length). Briefly, peptides were separated with a gradient of 2–60% acetonitrile (ACN) in 10 mM ammonium bicarbonate pH 10 over 80 min into 80 fractions. Then, the peptides were combined into 6 fractions and dried by vacuum centrifuging.

4.8. Resin-Assisted Enrichment of S-Nitrosylated Peptides

Enrichment of S-nitrosylated peptides was conducted as described [21,77] using Anti-TMT Resin (Thermo Scientific, Waltham, MA, USA). The lyophilized peptides were resuspended in 1x TBS, transferred to 50 μL of prewashed Anti-TMT Resin and incubated overnight in the dark at 4 °C with rotation. After overnight incubation, the supernatant was removed and the resin was washed eight times (5 min/wash) with 1 column volume of TBS, and three times with 1 column volume of sterile H2O. Finally, the sample was eluted with 4 column volumes of TMT Elution Buffer (50% ACN, 0.4% TFA). The eluted fractions were combined and vacuum-dried. For LC-MS/MS analysis, the resulting peptides were desalted with C18 ZipTips (Millipore, Billerica, MA, USA) according to the manufacturer’s instructions.

4.9. LC-MS/MS Analysis of Enriched S-Nitrosylated Peptides

Enriched S-nitrosylated peptides dissolved with buffer A (2% ACN, 0.1% formic acid, FA) were separated using an EASY-nLC 1200 HPLC system and EASY-Spray source (Thermo Scientific, Waltham, MA, USA) with EASY-Spray PepMap RSLC C18 25 cm × 75 μm ID column (Thermo Scientific, Waltham, MA, USA). A linear gradient of buffer B (90% ACN, 0.1% FA) running at a flow rate of 500 nL/min was applied for sample elution. The elution started from 9% buffer B and increased to 23% buffer B. Then, the concentration of buffer B was gradually increased to 35% within 5 min followed by a linear increase in its concentration to 80% for 5 min. Buffer B concentration was maintained at 80% for 2 min and then decreased to 5% within 1 min, followed by maintenance at 5% for 10 min. Finally, the spectra of first-grade MS were acquired during a scan scope of 350 to 1600 m/z in the resolution of 1.2 × 106. The spectra of second-grade MS were obtained with the parameter set up as follows: resolution = 1.5 × 105; maximum injection time = 100 ms; AGC target = 1 × 105. The mode of second-grade MS spectra was high-energy collisional dissociation (HCD) and its normalized collision energy was set to 30 eV. Quality control sample was also included and was analyzed in the same way during the LC-MS/MS analysis of enriched S-nitrosylated peptides.

4.10. Data Processing and Peptide Identification

Peptides and proteins were identified using the Proteome Discoverer software version 1.4 (Thermo Scientific, Waltham, MA, USA) combined with Mascot 2.3 search engines (Matrix Science, LDN, UK). The MS/MS spectra were queried against the Toxoplasma gondii ME49 strain database (http://www.toxodb.org/common/downloads/release-10.0/TgondiiME49/fasta/data/, accessed on 31 January 2014). Parameters of the search included: peptide mass tolerance = 20 ppm; enzyme = trypsin; fragment mass tolerance = 0.05 Da. Dynamic modifications harbored carbamidomethylation (C), iodoTMTsixplex (C) and methionine oxidation. The criteria applied to filter resulting peptides were false discovery rate of less than 0.01 and a confidence level of 95% were maximum 5%.

4.11. Bioinformatics Analysis and Results Presentation

Group-based Prediction System for SNO 1.0 (GPS SNO 1.0, ver. 1.0, available at http://sno.biocuckoo.org/ accessed on 16 October 2023) was used to predict plausible S-nitrosylated proteins harboring S-nitrosylation sites with default high threshold among the proteome data of T. gondii [78,79]. To obtain the probable S-nitrosylation motifs of S-nitrosylated peptides characterized in our research, the Motif-X algorithm [80] was utilized to analyze the bias of amino acid residues approximating S-nitrosylation sites and investigate motif consensus sequences for protein S-nitrosylation. The logo-like representation was used to graphically display motifs created in the alignment. Subcellular localization of nitrosylated proteins was predicted by using the WoLF PSORT (ver. 0.2, https://wolfpsort.hgc.jp accessed on 16 October 2023). Subsequently, GO annotation was conducted by applying the UniProt-GOA (http://www.ebi.ac.uk/goa/, accessed on 3 May 2022) database. The InterProScan software (ver. 5.0) was used to annotate protein’s GO function stemming from protein sequence alignment method in case of absence of annotation by UniProt-GOA database. Using GO (ver. 4.0, Open Biological and Biomedical Ontology Foundry, San Francisco, CA, USA, http://www.geneontology.org accessed on 16 October 2023) analysis, S-nitrosylated proteins were categorized into three classes, including molecular function, biological process and cell component. The KEGG (ver. 89.1, Institute for Chemical Research, Kyoto University, Kyoto, Japan, http://www.kegg.jp/kegg/ accessed on 16 October 2023) analysis was performed to annotate S-nitrosylated proteins to KEGG pathways. Meanwhile, InterProScan software (ver.5.0) and InterPro domain database were applied to annotate the protein domains based on protein sequence alignment. The GO/KEGG/domain enrichment analysis of all identified proteins was performed using a two-tailed Fisher’s exact test. The interaction network S-nitrosylated proteins involved were predicted using the STRING database and the PPI network was represented by Cytoscape software. The PPIs whose combined score was >0.9 were subjected to further interaction network analysis.

5. Conclusions

In this study, we reported the first S-nitrosylated proteomic profile of T. gondii using MS in combination with resin-assisted enrichment. We found 637 S-nitrosylated proteins, more than half of which were localized in the nucleus or cytoplasm. Of the seven identified motifs, five and two contained lysine and isoleucine, respectively. GO enrichment revealed that S-nitrosylated proteins were primarily located in the inner membrane of mitochondria and other organelles. These S-nitrosylated proteins participated in diverse biological and metabolic processes, including organic acid binding, carboxylic acid binding ribose and the phosphate biosynthetic process, indicating that S-nitrosylation contributes to the regulation of the T. gondii function. S-nitrosylated proteins of T. gondii were mainly involved in glycolysis/gluconeogenesis and aminoacyl-tRNA biosynthesis, suggesting that S-nitrosylation plays a crucial role in glycolysis in T. gondii. We found that 27 ribosomal proteins and 11 microneme proteins out of 22 secretory proteins were S-nitrosylated proteins, indicating that proteins in the ribosome and microneme were predominantly S-nitrosylated. PPI analysis identified three subnetworks: high-relevancy ribosome, RNA transport and chaperonin complex components. These networks demonstrated that S-nitrosylated proteins in T. gondii were associated with protein translation in the ribosome, gene transcription, invasion and proliferation of T. gondii. Our results will be a valuable resource for the ongoing investigation of the functions of S-nitrosylation. Comprehensive studies performed to unravel the functions of some prominent S-nitrosylated proteins in T. gondii are warranted. A comparative analysis of S-nitrosylated proteomic profiles among bradyzoites, tachyzoites and oocysts in T. gondii and between divergent genotypes of T. gondii should be performed, which in turn will promote the elucidation of the development and virulence of T. gondii.

Supplementary Materials

The following supporting information can be downloaded at: https://www.mdpi.com/article/10.3390/molecules28217329/s1, Figure S1: Bubble chart of GO enrichment analysis of the S-nitrosylated protein according to cellular component in Toxoplasma gondii. The y-axis denotes the terms of GO enrichment and the x-axis represents the Rich factors of the GO terms. Rich factor refers to the ratio of the quantity of S-nitrosylated proteins in the GO terms to the quantity of total S-nitrosylated proteins. Greater degrees of enrichment are indicated by higher Rich factors. Color and size of the node corresponding to GO terms refer to the p value and quantity of S-nitrosylated proteins of GO terms; Figure S2: Bubble chart of GO enrichment analysis of the S-nitrosylated protein according to molecular function in Toxoplasma gondii. The y-axis denotes the terms of GO enrichment and the x-axis represents the Rich factors of the GO terms. Rich factor refers to the ratio of the quantity of S-nitrosylated proteins in the GO terms to the quantity of total S-nitrosylated proteins. Greater degrees of enrichment are indicated by higher Rich factors. Color and size of the node corresponding to GO terms refer to the p value and quantity of S-nitrosylated proteins of GO terms; Figure S3: Bubble chart of GO enrichment analysis of the S-nitrosylated protein according to biological process in Toxoplasma gondii. The y-axis denotes the terms of GO enrichment and the x-axis represents the Rich factors of the GO terms. Rich factor refers to the ratio of the quantity of S-nitrosylated proteins in the GO terms to the quantity of total S-nitrosylated proteins. Greater degrees of enrichment are indicated by higher Rich factors. Color and size of the node corresponding to GO terms refer to the p value and quantity of S-nitrosylated proteins of GO terms; Table S1: List of S-nitrosylated peptides and proteins identified in Toxoplasma gondii; Table S2: List of S-nitrosylated sites and proteins predicted using GPS SNO 1.0.

Author Contributions

Z.W. and X.S. conceived and designed the research, analyzed the data and wrote the manuscript. Z.W. and J.L. performed the experiments. Q.Y. contributed reagents/materials/analysis tools. Z.W. critically revised the manuscript. All authors have read and agreed to the published version of the manuscript.

Funding

Project financial support was kindly provided by the Gansu Natural Science Foundation (No.21JR7RA823), Science and Technology Program of Lanzhou Science and Technology Bureau (No. 2023-3-46), the National Natural Science Foundation of China (No.32160843, No.31460659), the Open Funds of the State Key Laboratory of Veterinary Etiological Biology, Lanzhou Veterinary Research Institute, Chinese Academy of Agricultural Sciences (Grant No. SKLVEB2019KFKT005), the Special Fund for International Scientific and Technological Cooperation Projects of Gansu Province (No.144WCGA169), Key Research and Development Program of Gansu Province (No.18YF1FA080), Agricultural Biotechnology Research and Application Development Program of Agriculture and Rural affairs Department of Gansu Province (No. GNSW-2014-9) and Science and Technology Program of Lanzhou Science and Technology Bureau (No. 2017-4-103).

Institutional Review Board Statement

The animal study protocol was approved by the Animal Administration and Ethics Committee of Gansu Agricultural University (GSAU-Eth-VMC-2023-018 on 3 March 2023).

Informed Consent Statement

Not applicable.

Data Availability Statement

The identifier of ProteomeXchange Consortium depositing mass spectrometry data is PXD046083.

Acknowledgments

We thank Jingjie PTM Biolabs (Hangzhou, China) for technical assistance with the LC–MS/MS analysis.

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. Attias, M.; Teixeira, D.E.; Benchimol, M.; Vommaro, R.C.; Crepaldi, P.H.; De Souza, W. The life-cycle of Toxoplasma gondii reviewed using animations. Parasites Vectors 2020, 13, 588. [Google Scholar] [CrossRef] [PubMed]
  2. Robert-Gangneux, F.; Dardé, M.L. Epidemiology of and diagnostic strategies for toxoplasmosis. Clin. Microbiol. Rev. 2012, 25, 264–296. [Google Scholar] [CrossRef] [PubMed]
  3. Dubey, J.P.; Lago, E.G.; Gennari, S.M.; Su, C.; Jones, J.L. Toxoplasmosis in humans and animals in Brazil: High prevalence, high burden of disease, and epidemiology. Parasitology 2012, 139, 1375–1424. [Google Scholar] [CrossRef] [PubMed]
  4. Olsen, A.; Berg, R.; Tagel, M.; Must, K.; Deksne, G.; Enemark, H.L.; Alban, L.; Johansen, M.V.; Nielsen, H.V.; Sandberg, M.; et al. Seroprevalence of Toxoplasma gondii in domestic pigs, sheep, cattle, wild boars, and moose in the Nordic-Baltic region: A systematic review and meta-analysis. Parasite Epidemiol. Control 2019, 5, e00100. [Google Scholar] [CrossRef]
  5. Tenter, A.M.; Heckeroth, A.R.; Weiss, L.M. Toxoplasma gondii: From animals to humans. Int. J. Parasitol. 2000, 30, 1217–1258. [Google Scholar] [CrossRef]
  6. Tenter, A.M. Toxoplasma gondii in animals used for human consumption. Mem. Inst. Oswaldo Cruz 2009, 104, 364–369. [Google Scholar] [CrossRef]
  7. Stelzer, S.; Basso, W.; Benavides Silván, J.; Ortega-Mora, L.M.; Maksimov, P.; Gethmann, J.; Conraths, F.J.; Schares, G. Toxoplasma gondii infection and toxoplasmosis in farm animals: Risk factors and economic impact. Food Waterborne Parasitol. 2019, 15, e00037. [Google Scholar] [CrossRef]
  8. Zhang, Y.; Jiang, N.; Zhang, T.; Wang, D.; Feng, Y.; Sang, X.; Yang, N.; Chen, Q. Toxoplasma gondii genotype determines Tim-3 expression levels in splenic and circulatory T cells in mice. Front. Microbiol. 2018, 9, 2967. [Google Scholar] [CrossRef]
  9. Wang, C.; Cheng, W.; Yu, Q.; Xing, T.; Chen, S.; Liu, L.; Yu, L.; Du, J.; Luo, Q.; Shen, J.; et al. Toxoplasma Chinese 1 strain of WH3Δrop16I/III /gra15II genetic background contributes to abnormal pregnant outcomes in murine model. Front. Immunol. 2018, 9, 1222. [Google Scholar] [CrossRef]
  10. Chen, L.F.; Han, X.L.; Li, F.X.; Yao, Y.Y.; Fang, J.P.; Liu, X.J.; Li, X.C.; Wu, K.; Liu, M.; Chen, X.G. Comparative studies of Toxoplasma gondii transcriptomes: Insights into stage conversion based on gene expression profiling and alternative splicing. Parasites Vectors 2018, 11, 402. [Google Scholar] [CrossRef]
  11. Dubey, J.P.; Lindsay, D.S.; Speer, C.A. Structures of Toxoplasma gondii tachyzoites, bradyzoites, and sporozoites and biology and development of tissue cysts. Clin. Microbiol. Rev. 1998, 11, 267–299. [Google Scholar] [CrossRef]
  12. Dubey, J.P. History of the discovery of the life cycle of Toxoplasma gondii. Int. J. Parasitol. 2009, 39, 877–882. [Google Scholar] [CrossRef]
  13. Martorelli Di Genova, B.; Wilson, S.K.; Dubey, J.P.; Knoll, L.J. Intestinal delta-6-desaturase activity determines host range for Toxoplasma sexual reproduction. PLoS Biol. 2019, 17, e3000364. [Google Scholar] [CrossRef]
  14. Kibe, M.K.; Coppin, A.; Dendouga, N.; Oria, G.; Meurice, E.; Mortuaire, M.; Madec, E.; Tomavo, S. Transcriptional regulation of two stage-specifically expressed genes in the protozoan parasite Toxoplasma gondii. Nucleic Acids Res. 2005, 33, 1722–1736. [Google Scholar] [CrossRef]
  15. Gutierrez-Escobar, A.J.; Gómez-Marin, J.E. Toxoplasma gondii: Identification of a putative nitric oxide synthase motif DNA sequence. Exp. Parasitol. 2005, 111, 211–218. [Google Scholar] [CrossRef]
  16. Gutierrez-Escobar, A.J.; Arenas, A.F.; Villoria-Guerrero, Y.; Padilla-Londoño, J.M.; Gómez-Marin, J.E. Toxoplasma gondii: Molecular cloning and characterization of a nitric oxide synthase-like protein. Exp. Parasitol. 2008, 119, 358–363. [Google Scholar] [CrossRef] [PubMed]
  17. Toledo, J.C., Jr.; Augusto, O. Connecting the chemical and biological properties of nitric oxide. Chem. Res. Toxicol. 2012, 25, 975–989. [Google Scholar] [CrossRef] [PubMed]
  18. Moldogazieva, N.T.; Mokhosoev, I.M.; Feldman, N.B.; Lutsenko, S.V. ROS and RNS signalling: Adaptive redox switches through oxidative/nitrosative protein modifications. Free Radic. Res. 2018, 52, 507–543. [Google Scholar] [CrossRef] [PubMed]
  19. Koo, S.J.; Spratt, H.M.; Soman, K.V.; Stafford, S.; Gupta, S.; Petersen, J.R.; Zago, M.P.; Kuyumcu-Martinez, M.N.; Brasier, A.R.; Wiktorowicz, J.E.; et al. S-Nitrosylation proteome profile of peripheral blood mononuclear cells in human heart failure. Int. J. Proteom. 2016, 2016, 1384523. [Google Scholar] [CrossRef]
  20. Hlaing, K.H.; Clément, M.V. Formation of protein S-nitrosylation by reactive oxygen species. Free Radic. Res. 2014, 48, 996–1010. [Google Scholar] [CrossRef]
  21. Mule, S.N.; Manchola, N.C.; de Oliveira, G.S.; Pereira, M.; Magalhães, R.; Teixeira, A.A.; Colli, W.; Alves, M.; Palmisano, G. Proteome-wide modulation of S-nitrosylation in Trypanosoma cruzi trypomastigotes upon interaction with the host extracellular matrix. J. Proteom. 2021, 231, 104020. [Google Scholar] [CrossRef] [PubMed]
  22. Seth, D.; Hess, D.T.; Hausladen, A.; Wang, L.; Wang, Y.J.; Stamler, J.S. A multiplex enzymatic machinery for cellular protein S-nitrosylation. Mol. Cell 2018, 69, 451–464. [Google Scholar] [CrossRef] [PubMed]
  23. Stomberski, C.T.; Hess, D.T.; Stamler, J.S. Protein S-Nitrosylation: Determinants of specificity and enzymatic regulation of s-nitrosothiol-based signaling. Antioxid. Redox Signal. 2019, 30, 1331–1351. [Google Scholar] [CrossRef] [PubMed]
  24. Evangelista, A.M.; Kohr, M.J.; Murphy, E. S-nitrosylation: Specificity, occupancy, and interaction with other post-translational modifications. Antioxid. Redox Signal. 2013, 19, 1209–1219. [Google Scholar] [CrossRef] [PubMed]
  25. Zhou, H.L.; Stomberski, C.T.; Stamler, J.S. Cross talk between S-nitrosylation and phosphorylation involving kinases and nitrosylases. Circ. Res. 2018, 122, 1485–1487. [Google Scholar] [CrossRef]
  26. Wolhuter, K.; Whitwell, H.J.; Switzer, C.H.; Burgoyne, J.R.; Timms, J.F.; Eaton, P. Evidence against stable protein S-nitrosylation as a widespread mechanism of post-translational regulation. Mol. Cell 2018, 69, 438–450. [Google Scholar] [CrossRef]
  27. Nie, L.B.; Liang, Q.L.; Du, R.; Elsheikha, H.M.; Han, N.J.; Li, F.C.; Zhu, X.Q. Global Proteomic analysis of lysine malonylation in Toxoplasma gondii. Front. Microbiol. 2020, 11, 776. [Google Scholar] [CrossRef]
  28. Horton, P.; Park, K.J.; Obayashi, T.; Fujita, N.; Harada, H.; Adams-Collier, C.J.; Nakai, K. WoLF PSORT: Protein localization predictor. Nucleic Acids Res. 2007, 35, W585–W587. [Google Scholar] [CrossRef]
  29. Cheng, W.H.; Huang, K.Y.; Ong, S.C.; Ku, F.M.; Huang, P.J.; Lee, C.C.; Yeh, Y.M.; Lin, R.; Chiu, C.H.; Tang, P. Protein cysteine S-nitrosylation provides reducing power by enhancing lactate dehydrogenase activity in Trichomonas vaginalis under iron deficiency. Parasites Vectors 2020, 13, 477. [Google Scholar] [CrossRef]
  30. Wang, Z.X.; Zhou, C.X.; Elsheikha, H.M.; He, S.; Zhou, D.H.; Zhu, X.Q. Proteomic differences between developmental stages of Toxoplasma gondii revealed by iTRAQ-based quantitative proteomics. Front. Microbiol. 2017, 8, 985. [Google Scholar] [CrossRef]
  31. Van Poppel, N.F.; Welagen, J.; Vermeulen, A.N.; Schaap, D. The complete set of Toxoplasma gondii ribosomal protein genes contains two conserved promoter elements. Parasitology 2006, 133 Pt 1, 19–31. [Google Scholar] [CrossRef] [PubMed]
  32. Carruthers, V.B. Armed and dangerous: Toxoplasma gondii uses an arsenal of secretory proteins to infect host cells. Parasitol. Int. 1999, 48, 1–10. [Google Scholar] [CrossRef] [PubMed]
  33. Zhou, C.X.; Zhu, X.Q.; Elsheikha, H.M.; He, S.; Li, Q.; Zhou, D.H.; Suo, X. Global iTRAQ-based proteomic profiling of Toxoplasma gondii oocysts during sporulation. J. Proteom. 2016, 148, 12–19. [Google Scholar] [CrossRef]
  34. Bargieri, D.; Lagal, V.; Andenmatten, N.; Tardieux, I.; Meissner, M.; Ménard, R. Host cell invasion by apicomplexan parasites: The junction conundrum. PLoS Pathog. 2014, 10, e1004273. [Google Scholar] [CrossRef] [PubMed]
  35. Saouros, S.; Edwards-Jones, B.; Reiss, M.; Sawmynaden, K.; Cota, E.; Simpson, P.; Dowse, T.J.; Jäkle, U.; Ramboarina, S.; Shivarattan, T.; et al. A novel galectin-like domain from Toxoplasma gondii micronemal protein 1 assists the folding, assembly, and transport of a cell adhesion complex. J. Biol. Chem. 2005, 280, 38583–38591. [Google Scholar] [CrossRef]
  36. Dodangeh, S.; Daryani, A.; Sharif, M.; Aghayan, S.A.; Pagheh, A.S.; Sarvi, S.; Rezaei, F. A systematic review on efficiency of microneme proteins to induce protective immunity against Toxoplasma gondii. Eur. J. Clin. Microbiol. Infect. Dis. 2019, 38, 617–629. [Google Scholar] [CrossRef]
  37. Liu, Q.; Li, F.C.; Zhou, C.X.; Zhu, X.Q. Research advances in interactions related to Toxoplasma gondii microneme proteins. Exp. Parasitol. 2017, 176, 89–98. [Google Scholar] [CrossRef]
  38. Genestra, M.; de Souza, W.J.; Cysne-Finkelstein, L.; Leon, L.L. Comparative analysis of the nitric oxide production by Leishmania sp. Med. Microbiol. Immunol. 2003, 192, 217–223. [Google Scholar] [CrossRef]
  39. Gould, N.; Doulias, P.T.; Tenopoulou, M.; Raju, K.; Ischiropoulos, H. Regulation of protein function and signaling by reversible cysteine S-nitrosylation. J. Biol. Chem. 2013, 288, 26473–26479. [Google Scholar] [CrossRef]
  40. Jortzik, E.; Wang, L.; Becker, K. Thiol-based posttranslational modifications in parasites. Antioxid. Redox Signal. 2012, 17, 657–673. [Google Scholar] [CrossRef]
  41. Tryon, J.C.; Weidner, E.; Larson, A.D.; Hart, L.T. A rapid method for isolating purified Toxoplasma tachyzoites from peritoneal exudate and cell culture. J. Parasitol. 1978, 64, 1127–1129. [Google Scholar] [CrossRef] [PubMed]
  42. Wu, L.; Chen, S.X.; Jiang, X.G.; Fu, X.L.; Shen, Y.J.; Cao, J.P. Separation and purification of Toxoplasma gondii tachyzoites from in vitro and in vivo culture systems. Exp. Parasitol. 2012, 130, 91–94. [Google Scholar] [CrossRef] [PubMed]
  43. Khan, A.; Grigg, M.E. Toxoplasma gondii: Laboratory Maintenance and Growth. Curr. Protoc. Microbiol. 2017, 44, 20C.1.1–20C.1.17. [Google Scholar] [CrossRef] [PubMed]
  44. Dahl, R.J.; Johnson, A.M. Purification of Toxoplasma gondii from host cells. J. Clin. Pathol. 1983, 36, 602–604. [Google Scholar] [CrossRef]
  45. Li, F.C.; Nie, L.B.; Elsheikha, H.M.; Yin, F.Y.; Zhu, X.Q. Lysine crotonylation is widespread on proteins of diverse functions and localizations in Toxoplasma gondii. Parasitol. Res. 2021, 120, 1617–1626. [Google Scholar] [CrossRef]
  46. Guo, J.; Gaffrey, M.J.; Su, D.; Liu, T.; Camp, D.G., II; Smith, R.D.; Qian, W.J. Resin-assisted enrichment of thiols as a general strategy for proteomic profiling of cysteine-based reversible modifications. Nat. Protoc. 2014, 9, 64–75. [Google Scholar] [CrossRef]
  47. Derakhshan, B.; Wille, P.C.; Gross, S.S. Unbiased identification of cysteine S-nitrosylation sites on proteins. Nat. Protoc. 2007, 2, 1685–1691. [Google Scholar] [CrossRef]
  48. Su, D.; Shukla, A.K.; Chen, B.; Kim, J.S.; Nakayasu, E.; Qu, Y.; Aryal, U.; Weitz, K.; Clauss, T.R.; Monroe, M.E.; et al. Quantitative site-specific reactivity profiling of S-nitrosylation in mouse skeletal muscle using cysteinyl peptide enrichment coupled with mass spectrometry. Free Radic. Biol. Med. 2013, 57, 68–78. [Google Scholar] [CrossRef]
  49. Yu, L.; Dai, Z.; Zhang, Y.; Iqbal, S.; Lu, S.; Guo, L.; Yao, X. Proteome-wide identification of S-sulfenylated cysteines reveals metabolic response to freezing stress after cold acclimation in Brassica napus. Front. Plant Sci. 2022, 13, 1014295. [Google Scholar] [CrossRef]
  50. Barbacini, P.; Blottner, D.; Capitanio, D.; Trautmann, G.; Block, K.; Torretta, E.; Moriggi, M.; Salanova, M.; Gelfi, C. Effects of omega-3 and antioxidant cocktail supplement on prolonged bed rest: Results from serum proteome and sphingolipids analysis. Cells 2022, 11, 2120. [Google Scholar] [CrossRef]
  51. Wijasa, T.S.; Sylvester, M.; Brocke-Ahmadinejad, N.; Kummer, M.P.; Brosseron, F.; Gieselmann, V.; Heneka, M.T. Proteome profiling of s-nitrosylated synaptosomal proteins by isobaric mass tags. J. Neurosci. Methods 2017, 291, 95–100. [Google Scholar] [CrossRef] [PubMed]
  52. Zaman, U.; Richter, F.M.; Hofele, R.; Kramer, K.; Sachsenberg, T.; Kohlbacher, O.; Lenz, C.; Urlaub, H. Dithiothreitol (DTT) acts as a specific, UV-inducible cross-linker in elucidation of protein-RNA interactions. Mol. Cell. Proteom. 2015, 14, 3196–3210. [Google Scholar] [CrossRef] [PubMed]
  53. Cleland, W.W. Dithiothreitol, a new protective reagent for SH groups. Biochemistry 1964, 3, 480–482. [Google Scholar] [CrossRef] [PubMed]
  54. Yang, X.; Yin, X.; Liu, J.; Niu, Z.; Yang, J.; Shen, B. Essential role of pyrophosphate homeostasis mediated by the pyrophosphate-dependent phosphofructokinase in Toxoplasma gondii. PLoS Pathog. 2022, 18, e1010293. [Google Scholar] [CrossRef] [PubMed]
  55. Abdelbaset, A.E.; Fox, B.A.; Karram, M.H.; Abd Ellah, M.R.; Bzik, D.J.; Igarashi, M. Lactate dehydrogenase in Toxoplasma gondii controls virulence, bradyzoite differentiation, and chronic infection. PLoS ONE 2017, 12, e0173745. [Google Scholar] [CrossRef] [PubMed]
  56. Kavanagh, K.L.; Elling, R.A.; Wilson, D.K. Structure of Toxoplasma gondii LDH1: Active-site differences from human lactate dehydrogenases and the structural basis for efficient APAD+ use. Biochemistry 2004, 43, 879–889. [Google Scholar] [CrossRef] [PubMed]
  57. Al-Anouti, F.; Tomavo, S.; Parmley, S.; Ananvoranich, S. The expression of lactate dehydrogenase is important for the cell cycle of Toxoplasma gondii. J. Biol. Chem. 2004, 279, 52300–52311. [Google Scholar] [CrossRef]
  58. Pérez-Mato, I.; Castro, C.; Ruiz, F.A.; Corrales, F.J.; Mato, J.M. Methionine adenosyltransferase S-nitrosylation is regulated by the basic and acidic amino acids surrounding the target thiol. J. Biol. Chem. 1999, 274, 17075–17079. [Google Scholar] [CrossRef]
  59. Mnatsakanyan, R.; Markoutsa, S.; Walbrunn, K.; Roos, A.; Verhelst, S.H.L.; Zahedi, R.P. Proteome-wide detection of S-nitrosylation targets and motifs using bioorthogonal cleavable-linker-based enrichment and switch technique. Nat. Commun. 2019, 10, 2195. [Google Scholar] [CrossRef]
  60. Smith, J.G.; Aldous, S.G.; Andreassi, C.; Cuda, G.; Gaspari, M.; Riccio, A. Proteomic analysis of S-nitrosylated nuclear proteins in rat cortical neurons. Sci. Signal. 2018, 11, eaar3396. [Google Scholar] [CrossRef]
  61. Seth, D.; Stamler, J.S. The SNO-proteome: Causation and classifications. Curr. Opin. Chem. Biol. 2011, 15, 129–136. [Google Scholar] [CrossRef] [PubMed]
  62. Stamler, J.S.; Toone, E.J.; Lipton, S.A.; Sucher, N.J. (S)NO signals: Translocation, regulation, and a consensus motif. Neuron 1997, 18, 691–696. [Google Scholar] [CrossRef] [PubMed]
  63. Yang, H.; Wang, L.; Xie, Z.; Shao, S.; Wu, Y.; Xu, W.; Gu, B.; Wang, B. An improved sulfur-nitroso-proteome strategy for global profiling of sulfur-nitrosylated proteins and sulfur-nitrosylation sites in mice. J. Chromatogr. A 2023, 1705, 464162. [Google Scholar] [CrossRef] [PubMed]
  64. Wang, L.; Delahunty, C.; Prieto, J.H.; Rahlfs, S.; Jortzik, E.; Yates, J.R., 3rd; Becker, K. Protein S-nitrosylation in Plasmodium falciparum. Antioxid. Redox Signal. 2014, 20, 2923–2935. [Google Scholar] [CrossRef] [PubMed]
  65. Hertz, R.; Ben Lulu, S.; Shahi, P.; Trebicz-Geffen, M.; Benhar, M.; Ankri, S. Proteomic identification of S-nitrosylated proteins in the parasite Entamoeba histolytica by resin-assisted capture: Insights into the regulation of the Gal/GalNAc lectin by nitric oxide. PLoS ONE 2014, 9, e91518. [Google Scholar] [CrossRef]
  66. Warner, J.R.; Mcintosh, K.B. How common are extraribosomal functions of ribosomal proteins? Mol. Cell 2009, 34, 3–11. [Google Scholar] [CrossRef]
  67. Báñez-Vea, M.; Huang, H.; Martínez de Morentin, X.; Pérez, E.; Gato, M.; Zuazo, M.; Arasanz, H.; Fernández-Irigoyen, J.; Santamaría, E.; Fernandez-Hinojal, G.; et al. Characterization of Macrophage endogenous S-nitrosoproteome using a cysteine-specific phosphonate adaptable tag in combination with TiO2 chromatography. J. Proteome Res. 2018, 17, 1172–1182. [Google Scholar] [CrossRef]
  68. Pereira, M.; Soares, C.; Canuto, G.A.; Tavares, M.F.; Colli, W.; Alves, M.J. Down regulation of NO signaling in Trypanosoma cruzi upon parasite-extracellular matrix interaction: Changes in protein modification by nitrosylation and nitration. PLoS Negl. Trop. Dis. 2015, 9, e0003683. [Google Scholar] [CrossRef]
  69. Ju, Y.J.; Lee, H.W.; Choi, J.W.; Choi, M.S. The role of protein S-nitrosylation in protein misfolding-associated diseases. Life 2021, 11, 705. [Google Scholar] [CrossRef]
  70. Foroutan, M.; Zaki, L.; Ghaffarifar, F. Recent progress in microneme-based vaccines development against Toxoplasma gondii. Clin. Exp. Vaccine Res. 2018, 7, 93–103. [Google Scholar] [CrossRef]
  71. Soldati, D.; Dubremetz, J.F.; Lebrun, M. Microneme proteins: Structural and functional requirements to promote adhesion and invasion by the apicomplexan parasite Toxoplasma gondii. Int. J. Parasitol. 2001, 31, 1293–1302. [Google Scholar] [CrossRef] [PubMed]
  72. Liu, M.M.; Yuan, Z.G.; Peng, G.H.; Zhou, D.H.; He, X.H.; Yan, C.; Yin, C.C.; He, Y.; Lin, R.Q.; Song, H.Q.; et al. Toxoplasma gondii microneme protein 8 (MIC8) is a potential vaccine candidate against toxoplasmosis. Parasitol. Res. 2010, 106, 1079–1084. [Google Scholar] [CrossRef] [PubMed]
  73. Li, Z.Y.; Chen, J.; Petersen, E.; Zhou, D.H.; Huang, S.Y.; Song, H.Q.; Zhu, X.Q. Synergy of mIL-21 and mIL-15 in enhancing DNA vaccine efficacy against acute and chronic Toxoplasma gondii infection in mice. Vaccine 2014, 32, 3058–3065. [Google Scholar] [CrossRef]
  74. Liu, W.G.; Xu, X.P.; Chen, J.; Xu, Q.M.; Luo, S.L.; Zhu, X.Q. MIC16 gene represents a potential novel genetic marker for population genetic studies of Toxoplasma gondii. BMC Microbiol. 2016, 16, 101. [Google Scholar] [CrossRef] [PubMed]
  75. Chai, J.Y.; Lin, A.; Shin, E.H.; Oh, M.D.; Han, E.T.; Nan, H.W.; Lee, S.H. Laboratory passage and characterization of an isolate of Toxoplasma gondii from an ocular patient in Korea. Korean J. Parasitol. 2003, 41, 147–154. [Google Scholar] [CrossRef]
  76. Couatarmanach, A.; Andre, P.; Le Minous, D.; Martin, L.; Robert, R.; Deunff, J. In Vitro culture and cloning of Toxoplasma gondii in a newly established cell line derived from TG180. Int. J. Parasitol. 1991, 21, 129–132. [Google Scholar] [CrossRef]
  77. Zheng, W.Q.; Zhang, Y.; Yao, Q.; Chen, Y.; Qiao, X.; Wang, E.D.; Chen, C.; Zhou, X.L. Nitrosative stress inhibits aminoacylation and editing activities of mitochondrial threonyl-tRNA synthetase by S-nitrosation. Nucleic Acids Res. 2020, 48, 6799–6810. [Google Scholar] [CrossRef]
  78. Xue, Y.; Liu, Z.; Gao, X.; Jin, C.; Wen, L.; Yao, X.; Ren, J. GPS-SNO: Computational prediction of protein S-nitrosylation sites with a modified GPS algorithm. PLoS ONE 2010, 5, e11290. [Google Scholar] [CrossRef]
  79. Zahid, S.; Khan, R.; Oellerich, M.; Ahmed, N.; Asif, A.R. Differential S-nitrosylation of proteins in Alzheimer’s disease. Neuroscience 2014, 256, 126–136. [Google Scholar] [CrossRef]
  80. Schwartz, D.; Gygi, S.P. An iterative statistical approach to the identification of protein phosphorylation motifs from large-scale data sets. Nat. Biotechnol. 2005, 23, 1391–1398. [Google Scholar] [CrossRef]
Molecules 28 07329 g001
Figure 1. Properties of S-nitrosylated peptides in Toxoplasma gondii. (A) Number of S-nitrosylated peptides, identified proteins and S-nitrosylated sites. (B) Distribution of number of S-nitrosylated sites indicating that the most S-nitrosylated peptides possess a single S-nitrosylated site.
Figure 1. Properties of S-nitrosylated peptides in Toxoplasma gondii. (A) Number of S-nitrosylated peptides, identified proteins and S-nitrosylated sites. (B) Distribution of number of S-nitrosylated sites indicating that the most S-nitrosylated peptides possess a single S-nitrosylated site.
Molecules 28 07329 g001
Molecules 28 07329 g002
Figure 2. (A) Identification of S-nitrosylation-specific motifs using Motif-X. Sequence motif logos denoting identified S-nitrosylated site and composition position-specific amino acids adjacent to S-nitrosylated sites. The frequency of an amino acid emerging in specific positions is represented by the height of its logos. Acidic and basic residues are shown in blue and red, respectively. (B) Heat map showing amino acids at positions −10 to +10 from the S-nitrosylated lysine residue. Red and green indicate high and low frequencies, respectively.
Figure 2. (A) Identification of S-nitrosylation-specific motifs using Motif-X. Sequence motif logos denoting identified S-nitrosylated site and composition position-specific amino acids adjacent to S-nitrosylated sites. The frequency of an amino acid emerging in specific positions is represented by the height of its logos. Acidic and basic residues are shown in blue and red, respectively. (B) Heat map showing amino acids at positions −10 to +10 from the S-nitrosylated lysine residue. Red and green indicate high and low frequencies, respectively.
Molecules 28 07329 g002
Molecules 28 07329 g003
Figure 3. Gene Ontology (GO) classification of S-nitrosylated proteins in Toxoplasma. gondii. GO classification of characterized S-nitrosylated proteins based on biological process, cellular component and molecular function.
Figure 3. Gene Ontology (GO) classification of S-nitrosylated proteins in Toxoplasma. gondii. GO classification of characterized S-nitrosylated proteins based on biological process, cellular component and molecular function.
Molecules 28 07329 g003
Molecules 28 07329 g004
Figure 4. (A) Gene Ontology classification of characterized S-nitrosylated proteins based on subcellular localization. (B) COG/KOG analysis of S-nitrosylated proteins in Toxoplasma. gondii.
Figure 4. (A) Gene Ontology classification of characterized S-nitrosylated proteins based on subcellular localization. (B) COG/KOG analysis of S-nitrosylated proteins in Toxoplasma. gondii.
Molecules 28 07329 g004
Molecules 28 07329 g005
Figure 5. Gene Ontology (GO) enrichment analysis of S-nitrosylated proteins in Toxoplasma gondii according to cellular component, molecular function and biological process. The y- and x-axis denote enriched terms and Rich factor values of GO terms, respectively. Rich factor refers to S-nitrosylated proteins in GO terms divided by total S-nitrosylated proteins. A high degree of enrichment is indicated by high Rich factor values.
Figure 5. Gene Ontology (GO) enrichment analysis of S-nitrosylated proteins in Toxoplasma gondii according to cellular component, molecular function and biological process. The y- and x-axis denote enriched terms and Rich factor values of GO terms, respectively. Rich factor refers to S-nitrosylated proteins in GO terms divided by total S-nitrosylated proteins. A high degree of enrichment is indicated by high Rich factor values.
Molecules 28 07329 g005
Molecules 28 07329 g006
Figure 6. (A) Protein domain enrichment analysis of S-nitrosylated proteins in Toxoplasma gondii. The y- and x-axis represent significantly enriched protein domain categories and Rich factor of the protein domain, respectively. Rich factor refers to S-nitrosylated proteins harboring the protein domain divided by total S-nitrosylated proteins. A high degree of enrichment is indicated by high Rich factor values. The color and size of a node corresponding to a protein domain represent the p value and quantity of S-nitrosylated proteins in a protein domain. (B) Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway analysis of S-nitrosylated proteins in T. gondii. The y- and x-axis represent the KEGG pathways significantly enriched values and Rich factors of the pathways, respectively. Rich factor refers to the ratio of S-nitrosylated proteins in the pathway to the total S-nitrosylated proteins. Greater degrees of enrichment are indicated by higher Rich factor values. The color and size of a node corresponding to a pathway represent the p value and quantity of S-nitrosylated proteins in that pathway.
Figure 6. (A) Protein domain enrichment analysis of S-nitrosylated proteins in Toxoplasma gondii. The y- and x-axis represent significantly enriched protein domain categories and Rich factor of the protein domain, respectively. Rich factor refers to S-nitrosylated proteins harboring the protein domain divided by total S-nitrosylated proteins. A high degree of enrichment is indicated by high Rich factor values. The color and size of a node corresponding to a protein domain represent the p value and quantity of S-nitrosylated proteins in a protein domain. (B) Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway analysis of S-nitrosylated proteins in T. gondii. The y- and x-axis represent the KEGG pathways significantly enriched values and Rich factors of the pathways, respectively. Rich factor refers to the ratio of S-nitrosylated proteins in the pathway to the total S-nitrosylated proteins. Greater degrees of enrichment are indicated by higher Rich factor values. The color and size of a node corresponding to a pathway represent the p value and quantity of S-nitrosylated proteins in that pathway.
Molecules 28 07329 g006
Molecules 28 07329 g007
Figure 7. Protein–protein interaction networks of S-nitrosylated proteins in T. gondii (PPI, combined score ≥ 0.9). Nodes denote S-nitrosylated proteins and edges represent interactors of S-nitrosylated proteins. The color of an edge refers to the combined score of interactors.
Figure 7. Protein–protein interaction networks of S-nitrosylated proteins in T. gondii (PPI, combined score ≥ 0.9). Nodes denote S-nitrosylated proteins and edges represent interactors of S-nitrosylated proteins. The color of an edge refers to the combined score of interactors.
Molecules 28 07329 g007
Table 1. Description of S-nitrosylated motifs identified using Motif-X.
Table 1. Description of S-nitrosylated motifs identified using Motif-X.
No.*MotifMotif ScoreForegroundBackgroundFold
Increase
MatchesSizeMatchesSize
1.xxxxxxxxxxCxxxxxxxxxK8.72769834810131,2702.1
2.KxxxxxxxxxCxxxxxxxxxx8.42729074731126,4602.1
3.xxxxxxxxxxCxxxxxKxxxx7.02618354251121,7292.1
4.xxxxxxxxxxCxxxxKxxxxx7.20587744070117,4782.2
5.IxxxxxxxxxCxxxxxxxxxx6.41437162897113,4082.4
6.xxxxxxxxxxCKxxxxxxxxx6.15416732864110,5112.4
7.xxxxxxxxxxCxIxxxxxxxx6.86386322475107,6472.6
* Numbers 1–7 represent S-nitrosylated cysteine motifs.
Table 2. Ribosomal proteins in proteomics identification of cysteine S-nitrosylated proteins in Toxoplasma. gondii.
Table 2. Ribosomal proteins in proteomics identification of cysteine S-nitrosylated proteins in Toxoplasma. gondii.
Gene ProductGene IDNumber of S-Nitrosylated Site
ribosomal protein RPL3TGME49_2273602
ribosomal protein RPL4TGME49_3091202
ribosomal protein RPL7ATGME49_2615702
ribosomal protein RPL8TGME49_2040201
ribosomal protein RPL9TGME49_2845601
ribosomal protein RPL10TGME49_2887201
ribosomal protein RPL10ATGME49_2154703
ribosomal protein RPL14TGME49_2670601
ribosomal protein RPL17TGME49_2990501
ribosomal protein RPL21TGME49_2456802
ribosomal protein RPL22TGME49_2397601
ribosomal protein RPL23ATGME49_2380101
ribosomal protein RPL24TGME49_2443201
ribosomal protein RPL28TGME49_2292501
ribosomal protein RPL30TGME49_2322301
ribosomal protein RPL35ATGME49_2492501
ribosomal protein RPL37TGME49_2393301
ribosomal protein RPS2TGME49_3055202
ribosomal protein RPS3TGME49_2323002
ribosomal protein RPS3ATGME49_2327102
ribosomal protein RPS4TGME49_2074401
ribosomal protein RPS5TGME49_2423302
ribosomal protein RPL10TGME49_2887201
ribosomal protein RPS11TGME49_2269702
ribosomal protein RPS12TGME49_2053404
ribosomal protein RPS15TGME49_2133501
ribosomal protein RPS15ATGME49_2344501
ribosomal protein RPS20TGME49_2230501
Table 3. Secretory proteins (MICs, ROPs and GRAs) identified in the cysteine S-nitrosylated proteome in Toxoplasma. gondii.
Table 3. Secretory proteins (MICs, ROPs and GRAs) identified in the cysteine S-nitrosylated proteome in Toxoplasma. gondii.
Gene ProductGene IDNumber of S-Nitrosylated Site
MIC1 TGME49_2918902
MIC2 TGME49_2017804
MIC3TGME49_3195605
MIC4 TGME49_2080303
MIC6 TGME49_2185201
MIC7TGME49_2617802
MIC8 TGME49_2454903
MIC11 TGME49_2045301
MIC13 TGME49_2601902
MIC15 TGME49_2471952
MIC17A TGME49_2002501
ROP5 TGME49_3080901
ROP9 TGME49_2437301
ROP14 TGME49_3152201
ROP15 TGME49_2112901
ROP18 TGME49_2052501
ROP33 TGME49_2011301
RON2 TGME49_3001002
RON3 TGME49_2239204
RON4 TGME49_2290101
RON5 TGME49_3114703
GRA12TGME49_2886501
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Wang, Z.; Li, J.; Yang, Q.; Sun, X. Global Proteome-Wide Analysis of Cysteine S-Nitrosylation in Toxoplasma gondii. Molecules 2023, 28, 7329. https://doi.org/10.3390/molecules28217329

AMA Style

Wang Z, Li J, Yang Q, Sun X. Global Proteome-Wide Analysis of Cysteine S-Nitrosylation in Toxoplasma gondii. Molecules. 2023; 28(21):7329. https://doi.org/10.3390/molecules28217329

Chicago/Turabian Style

Wang, Zexiang, Jia Li, Qianqian Yang, and Xiaolin Sun. 2023. "Global Proteome-Wide Analysis of Cysteine S-Nitrosylation in Toxoplasma gondii" Molecules 28, no. 21: 7329. https://doi.org/10.3390/molecules28217329

APA Style

Wang, Z., Li, J., Yang, Q., & Sun, X. (2023). Global Proteome-Wide Analysis of Cysteine S-Nitrosylation in Toxoplasma gondii. Molecules, 28(21), 7329. https://doi.org/10.3390/molecules28217329

Article Metrics

Back to TopTop